Results 181 to 190 of about 225,115 (385)

Inhibitors of phosphodiesterase as cancer therapeutics.

open access: yesEuropean journal of medicinal chemistry, 2018
Ting Peng   +7 more
semanticscholar   +1 more source

Canagliflozin Reprograms the Aging Hippocampus in Genetically Diverse UM‐HET3 Mice and Attenuates Alzheimer's‐Like Pathology

open access: yesAging Cell, EarlyView.
Canagliflozin enhances hippocampal function, reduces Aβ pathology, and improves cognitive function in male mice, while females show limited benefits, revealing sex‐specific neuroprotective responses across aging and Alzheimer's models. ABSTRACT Aging is the strongest risk factor for cognitive decline and Alzheimer's disease (AD), yet the mechanisms ...
Hashan Jayarathne   +11 more
wiley   +1 more source

Action of Venom Phosphodiesterase on Deoxyribonucleic Acid

open access: hybrid, 1961
Edward J. Williams   +2 more
openalex   +1 more source

Phosphodiesterase‐5 Inhibition and Alzheimer's Disease Risk: A Mendelian Randomisation Study

open access: yesAging Cell, EarlyView.
Preclinical studies suggest PDE5 inhibitors may improve cognition, but observational evidence on Alzheimer's disease (AD) risk is mixed. We performed a cis‐Mendelian randomisation analysis across four AD genome‐wide association studies (GWAS) datasets and a sex‐stratified analysis using UK Biobank data.
Marta Alcalde‐Herraiz   +9 more
wiley   +1 more source

High Altitude Pulmonary Edema Response to Continuous Airway Positive Pressure: A Randomized Controlled Trial: The HAPER CAPER Trial

open access: yesAcademic Emergency Medicine, EarlyView.
ABSTRACT Background Morbidity and mortality in cardiogenic pulmonary edema have been reduced by noninvasive positive‐pressure airway maneuvers. The value of continuous positive airway pressure (CPAP) for the treatment of high‐altitude pulmonary edema (HAPE) is uncertain.
Todd Bolotin   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy